<DOC>
	<DOCNO>NCT01437514</DOCNO>
	<brief_summary>The local recurrence rectal cancer one main problem fail treatment . The preoperative neoadjuvant ( chemo ) radiotherapy confirm reduce local recurrence rate , especially advanced rectal cancer . However local recurrence rate low 10-20 % totally , integrity mesorectum operation circumferential resection margin ( CRM ) critical factor local recurrence.So , advanced rectal cancer patient negative CRM complete mesorectum excision , may benefit neoadjuvant radiation.This trial mainly focus resectable advanced rectal cancer patient whose preoperative stage cT3/N+ . These patient divide low risk group high risk group accord preoperative CT , Endoscopic ultrasound , MRI , carry randomize trial two group respectively.The purpose trial confirm whether preoperative radiotherapy necessary advance rectal cancer patient , identify reason local recurrence , finally help make treatment decision advance resectable rectal cancer .</brief_summary>
	<brief_title>Effective Study Preoperative Short-course Radiotherapy Advanced Resectable Rectal Cancer</brief_title>
	<detailed_description>The colorectal cancer secondary common cancer among population . Every year , 's estimate 1,200,000 new case , China data 440,000 . The local recurrence ( LR ) lung liver metastasis critical problem confuse doctor , local recurrence rate 3 % -50 % , median rate 18.8 % 。 Now , multidisciplinary treatment become choice treatment rectal cancer , preoperative neoadjuvant ( chemo ) radiotherapy critical part treatment , various trial confirm preoperative chemoradiotherapy reduce postoperative local recurrence rate . Although preoperative radiotherapy decrease local recurrence , study show ca n't increase overall survival . Also large MRC study show , quality operation also critical local recurrence . main reason local recurrence think positive circumferential resection margin ( CRM ) remnant mesorectum . On hand , improvement TME surgery , local recurrence advance rectal cancer lower 20 % , preoperative radiation may benefit half patient , reduce local recurrence rate 7-10 % .over 80 % patient may treat simultaneously suffer adverse effect radiation.The aim study explore low risk portion advance rectal cancer patient necessary preoperative radiation , radiation benefit high risk group . In trial , operator divide resectable advanced rectal cancer patient ( cT3/N+ ) two subgroup accord preoperative CT , MRI EUS.firstly , criterion low risk group : tumor invade mesorectum &lt; =5mm lateral posterior mesorectum , anterior wall tumor invade mesorectal fat tissue , enlarge lymph node large 8mm ; high risk group : tumor invade mesorectum &gt; 5mm lateral posterior part , invade mesorectum anterior anterior mesorectum relatively thin , lymph node large 8mm . patient randomized radiation surgery surgery respectively . In low risk group presume local recurrence rate relatively low radiation improve LR , high risk group radiation significantly beneficial . Of preoperative radiation , two regimen , long-term chemoradiotherapy short-course radiotherapy . mostly , long-term regimen popular , total dose 50.4 Gy 25-28 fraction , compare short-term one dose 25 Gy 5 fraction , long-term regimen well effect reduce tumor invasion . For resectable patient negative CRM surgery , conclusion well . short-term radiation choose regimen study . Local recurrence 3 year follow choose primary endpoint . Proving two-sided hypothesis difference arm high risk group , calculation sample size base expect local recurrence rate 6 % radiation group compare 16 % surgery group , result altogether 210 patient ( Log-Rank-test , error 1st kind : α = 5 % two-sided , power = 80 % ) . As low risk group may low LR rate , totally 200 low risk patient plan recruit randomization , similar high risk group . Patient baseline characteristic disease factor summarize use descriptive statistic . The categorical parameter compare use two-sided Pearson 's χ2 test Fisher 's exact test , appropriate . All summary statistic time-to-event variable calculate accord Kaplan-Meier method compare mean log-rank test . SPSS software ( version 22.0 ; IBM , Chicago , IL ) use statistical analysis . A P value &lt; 0.05 consider significant .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>1. histologically verified adenocarcinoma rectum ; 2. low border tumor within 10cm anal verge ; 3. age 18 80 year ; 4. preoperative endosonography , MRI abdominopelvic CT diagnosis advance rectal cancer ( cT3/N+ ) ( detail two subgroup illustrate detailed description trial ) ; 5 . ECOS ≤ 2 6. evidence metastasis chest abdominopelvic CT. 1. colorectal cancer , cancer , simultaneously ; 2 . Locally recurrent rectal cancer ; 3. history malignant tumor within 5 year ( except skin cancer ) ; 4 . Pregnant lactate woman 5. contraindication preoperative adjuvant radiotherapy operation . 6. antitumor drug radiation trial . 7. discovery metastasis operation 8. worry local recurrence adverse effect radiation excessively ; 9. mental disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>rectal cancer</keyword>
	<keyword>Endosonography</keyword>
	<keyword>preoperative short-course radiotherapy</keyword>
	<keyword>preoperative adjuvant therapy</keyword>
	<keyword>neoadjuvant therapy</keyword>
	<keyword>short-term high-dose preoperative radiotherapy</keyword>
	<keyword>total mesorectal excision</keyword>
	<keyword>circumferential resection margin</keyword>
	<keyword>local recurrence</keyword>
	<keyword>overall survival</keyword>
	<keyword>metastasis</keyword>
	<keyword>complication</keyword>
</DOC>